Details for New Drug Application (NDA): 211636
✉ Email this page to a colleague
The generic ingredient in ALBENDAZOLE is albendazole. There are ten drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the albendazole profile page.
Summary for 211636
Tradename: | ALBENDAZOLE |
Applicant: | Chartwell Rx |
Ingredient: | albendazole |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 211636
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 200MG | ||||
Approval Date: | Jun 10, 2020 | TE: | RLD: | No |
Complete Access Available with Subscription